You're signed outSign in or to get full access.
Rosalind Advisors, Inc.
Rosalind Advisors, Inc. is an investment advisory firm headquartered in Toronto, Ontario. The firm serves as the advisor to hedge funds including the Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P., focusing on investments in the biopharmaceutical and healthcare sectors. The firm is led by Steven Salamon (President) and Gilad Aharon (Portfolio Manager), both based in Toronto. It primarily manages assets for pooled investment vehicles and institutional investors.
Investment Strategy
Rosalind Advisors, Inc. employs a value-oriented, research-driven investment approach focused on healthcare and life sciences, especially in the biotechnology sector. The firm specializes in deep fundamental analysis of public and sometimes private companies, building concentrated portfolios with meaningful positions in promising biotech firms. Rosalind Advisors actively manages positions with the aim to capitalize on both long-term growth and event-driven opportunities within the sector.
Latest 13F Filing Activity
Rosalind Advisors, Inc. filed their most recent 13F report on Jun 30, 2025 disclosing 28 equity positions with a total 13F market value of $211M. The fund increased holdings in Cytokinetics Inc., Rezolute Inc., Fennec Pharmaceuticals Inc. among other positions. Rosalind Advisors, Inc. reduced exposure to Abeona Therapeutics Inc., Verastem Inc., Myomo Inc. among others.
Top Holdings
Equity Positions (28)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
D DCTH | DELCATH SYS INC | 15.65% | $33.0M | 3,300,389 | $7.96 | $13.60 | +$4.0M |
F FENC | FENNEC PHARMACEUTICALS INC | 8.05% | $17.0M | 2,045,644 | $6.52 | $8.30 | +$6.1M |
C CYTK | CYTOKINETICS INC | 6.27% | $13.2M | 400,000 | $33.04 | $33.04 | +$13.2M |
O OCUL | OCULAR THERAPEUTIX INC | 5.36% | $11.3M | 1,218,700 | $7.31 | $9.28 | +$2.4M |
I IDYA | IDEAYA BIOSCIENCES INC | 5.09% | $10.7M | 511,132 | $16.38 | $21.02 | -$722.0K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more